期刊的影响因子--文章列表

期刊文章列表
Lin Zhang¹，Dongna Li¹，Pengrong Yi¹，Jiangwei Shi^2,3，Mengqing Guo¹，Qingsheng Yin^1,4，Dingbin Liu⁵，Pengwei Zhuang^1,4，Yanjun Zhang^1,4,2,3（State Key Laboratory of Component-based Chinese Medicine，Tianjin University of Traditional Chinese Medicine；First Teaching Hospital of Tianjin University of Traditional Chinese Medicine；National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion；Haihe Laboratory of Modern Chinese Medicine；State Key Laboratory of Medicinal Chemical Biology，Research Center for Analytical Sciences，and Tianjin Key Laboratory of Molecular Recognition and Biosensing，College of Chemistry，Nankai University）.Peripheral origin exosomal micro RNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment[J].Acta Pharmaceutica Sinica B,2023,第7期 Jingwen Dong，Chenfei Zhu，Ying Huang，Quanhao Li，Jing Li，Zheng Wang，Yixin Wang，Zhanwei Zhou，Minjie Sun（NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients，State Key Laboratory of Natural Medicines，Department of Pharmaceutics，China Pharmaceutical University）.Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator[J].Acta Pharmaceutica Sinica B,2023,第7期 Junwoo Lee¹，Dongwoo Khang^1,2,3,4（College of Medicine，Gachon University；Lee Gil Ya Cancer and Diabetes Institute，Gachon University；Gachon Advanced Institute for Health Science & Technology，Gachon University；Department of Physiology，College of Medicine，Gachon University）.Mucosal delivery of nanovaccine strategy against COVID-19 and its variants[J].Acta Pharmaceutica Sinica B,2023,第7期 Yi-Zheng Fang^1,2,3，Li Jiang^1,2,3，Qiaojun He^2,3,4，Ji Cao^1,2,3，Bo Yang^1,2（Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University；Center for Drug Safety Evaluation and Research of Zhejiang University）.Deubiquitination complex platform：A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes[J].Acta Pharmaceutica Sinica B,2023,第7期 Liang He¹，Ziwei Xu²，Xin Niu²，Rong Li¹，Fanhua Wang¹，Yu You²，Jingduo Gao²，Lei Zhao¹，Karan M.Shah³，Jian Fan⁴，Mingyao Liu²，Jian Luo¹（Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)，Tongji University School of Medicine；Shanghai Key Laboratory of Regulatory Biology，Institute of Biomedical Sciences and School of Life Sciences，East China Normal University；Department of Oncology and Metabolism，the Medical School，the University of Sheffield；Department of Orthopedics，Tongji Hospital，Tongji University School of Medicine）.GPRC5B protects osteoarthritis by regulation of autophagy signaling[J].Acta Pharmaceutica Sinica B,2023,第7期 Qiaobo Xie¹，Yanyan Chu²，Wenmin Yuan³，Yanan Li⁴，Keqin Li¹，Xinfeng Wu¹，Xiaohui Liu¹，Rui Xu¹，Shuxiang Cui⁴，Xianjun Qu¹（Department of Pharmacology，School of Basic Medical Sciences，Capital Medical University；Ocean University of China，School of Medicine and Pharmacy；Marine Biomedical Research Institute of Qingdao；Department of Toxicology and Sanitary Chemistry，Beijing Key Laboratory of Environmental Toxicology，School of Public Health，Capital Medical University）.Activation of insulin-like growth factor-1 receptor （IGF-1R） promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-Ⅰ[J].Acta Pharmaceutica Sinica B,2023,第7期 Shuai Xiong¹，Hui Xiao¹，Meng Sun¹，Yunjie Liu¹，Ling Gao¹，Ke Xu¹，Haiying Liang¹，Nan Jiang²，Yuhui Lin¹，Lei Chang¹，Haiyin Wu^1,3，Dongya Zhu^1,3，Chunxia Luo^1,3（Department of Pharmacology，School of Pharmacy，Nanjing Medical University；Department of Medicinal Chemistry，School of Pharmacy，Nanjing Medical University；Collaborative Innovation Center for Cardiovascular Disease Translational Medicine，Nanjing Medical University）.Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window[J].Acta Pharmaceutica Sinica B,2023,第7期 Zhuang Li¹，Na Liu²，Wanzhen Yang²，Jie Tu²，Yahui Huang²，Wei Wang^1,3，Chunquan Sheng²（State Key Laboratory of Bioengineering Reactor，And Shanghai Key Laboratory of New Drug Design，School of Pharmacy，East China University of Science & Technology；School of Pharmacy，Second Military Medical University (Naval Medical University)；Department of Pharmacology and Toxicology，College of Pharmacy，And BIO5 Institute，University of Arizona）.Controlling antifungal activity with light：Optical regulation of fungal ergosterol biosynthetic pathway with photo-responsive CYP51 inhibitors[J].Acta Pharmaceutica Sinica B,2023,第7期 Dayong Zheng¹，Jun Li²，Han Yan¹，Gang Zhang³，Wei Li¹，Edward Chu⁴，Ning Wei⁴（School of Pharmacy，North China University of Science and Technology；Basic Medical Science College，Liaoning University of Traditional Chinese Medicine；Division of Biology and Biological Engineering，California Institute of Technology；Department of Oncology and Cancer Therapeutics Program，Montefiore Einstein Cancer Center，Albert Einstein College of Medicine）.Emerging roles of Aurora-A kinase in cancer therapy resistance[J].Acta Pharmaceutica Sinica B,2023,第7期 Zhun Lin¹，Zhengyu Zou²，Zhe Pu¹，Minhao Wu²，Yuanqing Zhang¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Zhongshan School of Medicine，Sun Yat-sen University）.Application of microfluidic technologies on COVID-19 diagnosis and drug discovery[J].Acta Pharmaceutica Sinica B,2023,第7期 Letian Li¹，Jiayi Hao¹，Yuhang Jiang¹，Pengfei Hao¹，Yuwei Gao¹，Jing Chen¹，Guoqing Zhang¹，Ningyi Jin¹，Maopeng Wang²，Chang Li¹（Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses，Chinese Academy of Medical Sciences，Changchun Veterinary Research Institute，Chinese Academy of Agricultural Sciences；Wenzhou Key Laboratory for Virology and Immunology，Institute of Virology，Wenzhou University）.A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization[J].Acta Pharmaceutica Sinica B,2023,第7期 Lin Hou^1,2,3，Xueyuan Peng^1,2，Ruiting Wang^1,2，Yifei Wang^1,2，Hong Li^1,2，Huijuan Zhang^1,2,3，Yun Zhang^1,2,3，Zhenzhong Zhang^1,2,3（School of Pharmaceutical Sciences，Zhengzhou University；Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases，Zhengzhou University；Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University）.Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment[J].Acta Pharmaceutica Sinica B,2023,第7期 Luchen Sun¹，Nanfei Yang²，Bing Chen³，Yuncheng Bei⁴，Zisheng Kang⁵，Can Zhang⁵，Nan Zhang⁶，Peipei Xu³，Wei Yang⁷，Jia Wei⁴，Jiangqiong Ke¹，Weijian Sun¹，Xiaokun Li⁸，Pingping Shen^1,9,10（The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University；School of Pharmaceutical Science，Wenzhou Medical University；Department of Hematology，the Affiliated Drum Tower Hospital of Nanjing University Medical School；The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital，the Affiliated Hospital of Nanjing University Medical School，Nanjing University；State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases，Center of Drug Discovery，China Pharmaceutical University；Centre of Micro/Nano Manufacturing Technology (MNMT-Dublin)，School of Mechanical & Materials Engineering，University College Dublin；Department of Surgery，Division of Cancer Biology and Therapeutics，Cedars-Sinai Medical Center；Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine，Vision and Brain Health) & School of Pharmaceutical Science，Wenzhou Medical University；Department of Urology，Drum Tower Hospital，Medical School of Nanjing University，Institute of Urology，Nanjing University；Shenzhen Research Institute of Nanjing University）.A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy[J].Acta Pharmaceutica Sinica B,2023,第7期 Jingnan Zhang，Ze Zhang，Zhenlin Huang，Manlin Li，Fan Yang，Zeqi Wu，Qian Guo，Xiyu Mei，Bin Lu，Changhong Wang，Zhengtao Wang，Lili Ji（The MOE Key Laboratory for Standardization of Chinese Medicines，Shanghai Key Laboratory of Compound Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines，Institute of Chinese Materia Medica，Shanghai University of Traditional Chinese Medicine）.Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial—mesenchymal transition via directly targeting TGFβR1[J].Acta Pharmaceutica Sinica B,2023,第7期 Yiqun Li，Mingrui Yang，Yanan Nan，Jiaming Wang，Sanjiao Wang，Dongxiao Cui，Jiajian Guo，Pengfei He，Wenxin Dai，Shuqi Zhou，Yue Zhang，Wenfu Ma（School of Life Science，Beijing University of Chinese Medicine）.SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor[J].Acta Pharmaceutica Sinica B,2023,第7期 Xiangshi Sun¹，Xiaoxuan Xu²，Jue Wang²，Xinyue Zhang³，Zitong Zhao²，Xiaochen Liu²，Guanru Wang²，Lesheng Teng⁴，Xia Chen¹，Dangge Wang^2,5，Yaping Li^2,6,3（Department of Pharmacology，College of Basic Medical Sciences，Jilin University；State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine；School of Life Sciences，Jilin University；Yantai Key Laboratory of Nanomedicine & Advanced Preparations，Yantai Institute of Materia Medica；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery）.Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells[J].Acta Pharmaceutica Sinica B,2023,第7期 Ya-Li Sang^1,2,3，Christophe Pannecouque⁴，Erik De Clercq⁴，Shuai Wang^1,2，Fen-Er Chen^1,2,3（Department of Chemistry，Engineering Center of Catalysis and Synthesis for Chiral Molecules，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs；School of Science，Harbin Institute of Technology (Shenzhen)；Rega Institute for Medical Research，KU Leuven）.Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability[J].Acta Pharmaceutica Sinica B,2023,第7期 Mojtaba Shamsipur，Atefeh Ghavidast，Afshin Pashabadi（Department of Chemistry，Razi University）.Phototriggered structures：Latest advances in biomedical applications[J].Acta Pharmaceutica Sinica B,2023,第7期 Yi Zhou^1,2，Yingling Miao²，Qiudi Huang²，Wenwen Shi²，Jiacui Xie^2,3，Jiachang Lin²，Pei Huang^2,3，Chengfeng Yue^2,4，Yuan Qin²，Xiyong Yu²，He Wang⁴，Linghao Qin³，Jianhai Chen¹（Nanfang Hospital，Southern Medical University；Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease and the Fifth Affiliated Hospital，School of Pharmaceutical Sciences，Guangzhou Medical University；School of Pharmacy，Guangdong Pharmaceutical University；Center of Cancer Research，The Second Affiliated Hospital，Guangzhou Medical University）.A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression[J].Acta Pharmaceutica Sinica B,2023,第7期 Aihua Wu，Afeng Yang，Qinli Tong，Guoguang Wei，Sihang Zhang，Sheng Yu，Chen Zhang，Jiaojiao Xu，Wei Lu（School of Pharmacy ＆ Minhang Hospital，Key Laboratory of Smart Drug Delivery，Ministry of Education，＆ State Key Laboratory of Molecular Engineering of Polymers，Fudan University）.A rationally designed cancer vaccine based on NIR-II fluorescence image-guided light-triggered remote control of antigen cross-presentation and autophagy[J].Acta Pharmaceutica Sinica B,2023,第7期 Yanqiong Zhang¹，Xin Li¹，Yulong Shi²，Tong Chen³，Zhijian Xu²，Ping Wang¹，Meng Yu¹，Wenjia Chen¹，Bing Li¹，Zhiwei Jing⁴，Hong Jiang¹，Lu Fu¹，Wenjing Gao¹，Yanhua Jiang⁴，Xia Du⁵，Zipeng Gong⁶，Weiliang Zhu²，Hongjun Yang⁷，Haiyu Xu¹（Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；State Key Laboratory of Drug Research，Drug Discovery and Design Center，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；National Resource Center for Chinese Materia Medica，Chinese Academy of Chinese Medical Sciences；Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences；Shaanxi Academy of Traditional Chinese Medicine；State Key Laboratory of Functions and Applications of Medicinal Plants，Guizhou Provincial Key Laboratory of Pharmaceutics，Guizhou Medical University；China Academy of Chinese Medical Sciences）.ETCM v2.0：An update with comprehensive resource and rich annotations for traditional Chinese medicine[J].Acta Pharmaceutica Sinica B,2023,第6期 Yanlin Luo^1,2,3，Yibing Chen⁴，Huan Jin²，Benxin Hou，Hongsheng Li⁶，Xiang Li⁷，Lingfeng Liu²，Yuan Zhou²，Yonghua Li²，Yong Sang Song⁸，Quentin Liu⁹，Zhengzhi Zou^2,10（Department of Gynecologic Oncology，the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital；MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science，Guangdong Provincial Key Laboratory of Laser Life Science，College of Biophotonics，South China Normal University；Institute of Clinical Pharmacology，School of Basic Medical Science，Academy of Medical Science，Zhengzhou University；Genetic and Prenatal Diagnosis Center，Department of Gynecology and Obstetrics，First Affiliated Hospital，Zhengzhou University；Department of General Surgery，the Third People’s Hospital of Hainan Province；Department of Breast Surgery，Affiliated Cancer Hospital & Institute of Guangzhou Medical University；Department of Pathophysiology，School of Basic Medical Sciences，Zhengzhou University；Department of Obstetrics and Gynecology，Cancer Research Institute，College of Medicine，Seoul National University；State Key Laboratory of Oncology in South China，Cancer Center，Sun Yat-sen University；Guangzhou Key Laboratory of Spectral Analysis and Functional Probes，College of Biophotonics，South China Normal University）.The suppression of cervical cancer ferroptosis by macrophages：The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes[J].Acta Pharmaceutica Sinica B,2023,第6期 Jiayi Luan¹，Ruotao Li²，Weiguo Xu³，Huiying Sun¹，Qiqi Li¹，Di Wang¹，Shujun Dong¹，Jianxun Ding³（VIP Integrated Department，Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling，School and Hospital of Stomatology，Jilin University；Department of Hand and Foot Surgery，the First Hospital of Jilin University；Key Laboratory of Polymer Ecomaterials，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences）.Functional biomaterials for comprehensive periodontitis therapy[J].Acta Pharmaceutica Sinica B,2023,第6期 Bingbing Li¹，Chao Teng²，Huiling Yu^1,3，Xiaohong Jiang²，Xuyang Xing²，Qi Jiang²，Chenshi Lin²，Zongmin Zhao⁴，Ruifeng Zhang⁵，Wei He^2,6（Department of Anesthesiology，Affiliated Drum Tower of Nanjing University；School of Pharmacy，China Pharmaceutical University；Department of Anesthesiology，Women's Hospital of Nanjing Medical University，Nanjing Maternity and Child Health Care Hospital；Department of Pharmaceutical Sciences，College of Pharmacy，University of Illinois at Chicago；Department of Respiratory Medicine，Zhongda Hospital of Southeast University；Shanghai Skin Disease Hospital，Tongji University School of Medicine）.Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries[J].Acta Pharmaceutica Sinica B,2023,第6期 Xin Jin^1,2,3，Tingting Qiu¹，Li Li¹，Rilei Yu¹，Xiguang Chen²，Changgui Li⁴，Christopher G.Proud⁵，Tao Jiang¹（School of Medicine and Pharmacy，Ocean University of China and Laboratory for Marine Drugs and Bioproducts，Qingdao National Laboratory for Marine Science and Technology；College of Marine Life Sciences，Ocean University of China；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery；Shandong Provincial Key Laboratory of Metabolic Diseases，Qingdao Key Laboratory of Gout，Affiliated Hospital of Qingdao University Medical College，Qingdao University；Lifelong Health Theme，South Australian Health and Medical Research Institute）.Pathophysiology of obesity and its associated diseases[J].Acta Pharmaceutica Sinica B,2023,第6期 Yanping Wang^1,2，Yanfeng Gao¹，Yongchun Pan¹，Dongtao Zhou¹，Yuta Liu¹，Yi Yin¹，Jingjing Yang¹，Yuzhen Wang³，Yujun Song¹（College of Engineering and Applied Sciences，State Key Laboratory of Analytical Chemistry for Life Science，Nanjing University；Sino-French Engineer School，Nanjing University of Science and Technology；Key Laboratory of Flexible Electronics & Institute of Advanced Materials，Jiangsu National Synergistic Innovation Center for Advanced Materials，Nanjing Tech University）.Emerging trends in organ-on-a-chip systems for drug screening[J].Acta Pharmaceutica Sinica B,2023,第6期 Chao Chen¹，Wu Zhong²，Shiyu Du¹，Yayao Li¹，Yunfei Zeng²，Kunguo Liu¹，Jingjing Yang¹，Xiaoxiang Guan³，Xin Han¹（Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization，School of Medicine & Holistic Integrative Medicine，Nanjing University of Chinese Medicine；Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province，School of Medicine，Hunan Normal University；Department of Oncology，the First Affiliated Hospital of Nanjing Medical University）.Intelligent nanotherapeutic strategies for the delivery of CRISPR system[J].Acta Pharmaceutica Sinica B,2023,第6期 Yuehong Ren¹，Wei Wu^2,3，Xingwang Zhang¹（Department of Pharmaceutics，College of Pharmacy，Jinan University；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University）.The feasibility of oral targeted drug delivery：Gut immune to particulates?[J].Acta Pharmaceutica Sinica B,2023,第6期 Jialu Wu^1,2，Yue Wan³，Zhenxing Wu^1,2，Shengyu Zhang³，Dongsheng Cao⁴，Chang-Yu Hsieh¹，Tingjun Hou¹（Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University，College of Pharmaceutical Sciences，Zhejiang University；Carbon Silicon AI Technology Co.，Ltd.；Tencent Quantum Laboratory；Xiangya School of Pharmaceutical Sciences，Central South University）.MF-SuP-pK_a：Multi-fidelity modeling with subgraph pooling mechanism for pK_a prediction[J].Acta Pharmaceutica Sinica B,2023,第6期 Chen Shi^1,2，Cong Zhang¹，Zhiwen Fu¹，Jinmei Liu¹，Yuanfeng Zhou³，Bao Cheng⁴，Cong Wang¹，Shijun Li¹，Yu Zhang^1,2（Department of Pharmacy，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology；Hubei Province Clinical Research Center for Precision Medicine for Critical Illness；Department of Preclinical Translational Science，Shanghai Hansoh Biomedical Co.，Ltd.；Department of Chemistry，Shanghai Hansoh Biomedical Co.，Ltd.）.Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations[J].Acta Pharmaceutica Sinica B,2023,第6期首页上一页 3 4 5 6 7 下一页尾页共有11页，转到页

期刊文章列表